Atlas Trials

Activity of Abiraterone Acetate in the Management of Cushing's Syndrome in Patients With Adrenocortical Carcinoma

Clinical trial NCT03145285 · UNKNOWN

Trial details

NCT number
NCT03145285
Sponsor
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Cushing SyndromeAdrenocortical Carcinoma
Start date
2017-04-18
Primary completion
2020-04-18
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.